Levetiracetam Sandoz 100 Mg/Ml (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilizes neuronal firing and reduces hyperexcitability, helping to prevent the spread of seizure activity across the brain.

The specific dose and infusion rate are determined by the prescribing clinician based on the patient’s age, weight, renal function, and clinical response. Dosage should always follow the prescriber’s instructions.

Safety data for levetiracetam in pregnancy and lactation are limited. The prescriber must weigh potential benefits against possible risks to the fetus or infant, and discuss any concerns with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Levetiracetam has a distinct mechanism (SV2A binding) and a relatively low potential for drug‑drug interactions compared with many enzyme‑inducing antiepileptics such as carbamazepine or phenytoin. It is often chosen for patients who need a well‑tolerated adjunctive agent with minimal metabolic impact.

Levetiracetam Sandoz 100 Mg/Ml should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from direct light, moisture, and extreme temperature fluctuations to maintain stability.

The product is supplied as a sterile intravenous solution. It is administered by slow IV infusion under the supervision of qualified healthcare professionals, following the infusion rate and duration prescribed by the treating physician.

Serious risks include severe allergic reactions such as anaphylaxis, life‑threatening skin conditions like Stevens‑Johnson syndrome, blood dyscrasias, and significant mood or behavioral changes including depression and suicidal thoughts. Immediate medical attention is required if any of these occur.

Patients with known hypersensitivity to levetiracetam or any component of the formulation should avoid this product. Caution is also advised for individuals with severe renal impairment, uncontrolled psychiatric disorders, or those taking medications that may markedly reduce levetiracetam efficacy.